Can a propensity score matching method be applied to assessing efficacy from single‐arm proof‐of‐concept trials in oncology?

As a result of the escalating number of new cancer treatments being developed and competition among pharmaceutical companies, decisions regarding how to proceed with phase III trials are frequently based on findings from either single‐arm phase I expansion cohorts or phase II studies that compare th...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Shu‐Wen, Su, Yu‐Cheng, Pallantla, Ravikumar, Channavazzala, Madhav, Kumar, Rukmini, Sheng, Yucheng, Wang, Hao, Wang, Crystal, Tse, Archie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508568/
https://www.ncbi.nlm.nih.gov/pubmed/37528543
http://dx.doi.org/10.1002/psp4.13014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508568/
https://www.ncbi.nlm.nih.gov/pubmed/37528543
http://dx.doi.org/10.1002/psp4.13014

Ejemplares similares